Trial intelligence / Profile preview

Intraoperative methadone for prevention of postoperative pain in orthopedic arthroplasty

2024-518059-50-00Phase 3Authorised

Sponsor
CHU Brugmann
Start
Mar 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative pain comparing Methadone hydrochloride arm with Sufentanil arm (2 arms). Primary endpoints: Total postoperative morphine consumption, Postoperative pain at rest and 4 more. Planned start Mar 2023; status: authorised.

02

Drugs

methadonesufentanil
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2024-518059-50-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-518059-50-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call